Johnson & Johnson

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4781601046
USD
227.50
-3.15 (-1.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
24,068.00
24,562.00
23,992.00
23,741.00
21,894.00
22,519.00
22,470.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
24,068.00
24,562.00
23,992.00
23,741.00
21,894.00
22,519.00
22,470.00
Raw Material Cost
7,964.00
8,162.00
7,265.00
7,481.00
7,259.00
7,231.00
6,924.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
418.00
490.00
377.00
432.00
287.00
268.00
300.00
Selling and Distribution Expenses
6,034.00
6,753.00
5,922.00
5,889.00
5,112.00
6,453.00
5,478.00
Other Expenses
307.70
377.80
331.60
310.00
293.90
505.10
465.20
Total Expenditure (Excl Depreciation)
17,493.00
19,183.00
16,880.00
16,902.00
15,597.00
19,003.00
17,354.00
Operating Profit (PBDIT) excl Other Income
6575
5379
7112
6839
6297
3516
5116
Other Income
604.00
1,109.60
797.70
534.00
801.00
605.00
1,232.00
Operating Profit (PBDIT)
9,183.00
8,499.60
9,686.70
9,316.00
8,870.00
6,017.00
8,194.00
Interest
418.00
490.00
377.00
432.00
287.00
268.00
300.00
Exceptional Items
-771.00
-1,032.60
-39.70
-450.00
6,820.00
34.00
-2,710.00
Gross Profit (PBDT)
16,104.00
16,400.00
16,727.00
16,260.00
14,635.00
15,288.00
15,546.00
Depreciation
2,004.00
2,011.00
1,777.00
1,943.00
1,772.00
1,896.00
1,846.00
Profit Before Tax
5,990.00
4,966.00
7,493.00
6,491.00
13,631.00
3,887.00
3,338.00
Tax
755.00
-150.00
2,341.00
954.00
2,632.00
456.00
644.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5,235.00
5,116.00
5,152.00
5,537.00
10,999.00
3,431.00
2,694.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5,235.00
5,116.00
5,152.00
5,537.00
10,999.00
3,431.00
2,694.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
5,235.00
5,116.00
5,152.00
5,537.00
10,999.00
3,431.00
2,694.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
81,186.00
81,544.00
79,277.00
78,473.00
78,109.00
71,490.00
70,158.00
Earnings per share (EPS)
2.14
2.1
2.12
2.29
4.54
1.41
1.11
Diluted Earnings per share
2.14
2.1
2.12
2.29
4.54
1.41
1.11
Operating Profit Margin (Excl OI)
27.32%
21.9%
29.64%
28.81%
28.76%
15.61%
22.77%
Gross Profit Margin
33.21%
28.41%
38.64%
35.53%
70.35%
25.68%
23.07%
PAT Margin
21.75%
20.83%
21.47%
23.32%
50.24%
15.24%
11.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.01% vs 2.38% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 2.33% vs -0.70% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 16.09% vs -16.86% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -14.69% vs 29.97% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Johnson & Johnson With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
24,068.00
19,292.00
4,776.00
24.76%
Other Operating Income
0.00
0.00
0.00
Total Operating income
24,068.00
19,292.00
4,776.00
24.76%
Raw Material Cost
7,964.00
3,372.00
4,592.00
136.18%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
418.00
123.00
295.00
239.84%
Selling and Distribution Expenses
6,034.00
3,132.00
2,902.00
92.66%
Other Expenses
307.70
367.90
-60.20
-16.36%
Total Expenditure (Excl Depreciation)
17,493.00
10,306.00
7,187.00
69.74%
Operating Profit (PBDIT) excl Other Income
6,575.00
8,986.00
-2,411.00
-26.83%
Other Income
604.00
35.60
568.40
1,596.63%
Operating Profit (PBDIT)
9,183.00
9,607.30
-424.30
-4.42%
Interest
418.00
123.00
295.00
239.84%
Exceptional Items
-771.00
-633.60
-137.40
-21.69%
Gross Profit (PBDT)
16,104.00
15,920.00
184.00
1.16%
Depreciation
2,004.00
585.70
1,418.30
242.15%
Profit Before Tax
5,990.00
8,265.00
-2,275.00
-27.53%
Tax
755.00
1,629.00
-874.00
-53.65%
Provisions and contingencies
0
0
0.00
Profit After Tax
5,235.00
6,636.00
-1,401.00
-21.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
5,235.00
6,636.00
-1,401.00
-21.11%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5,235.00
6,636.00
-1,401.00
-21.11%
Equity Capital
0
0
0.00
Face Value
1.00
0.00
0.00
Reserves
81,186.00
26,535.00
54,651.00
205.96%
Earnings per share (EPS)
2.14
7.02
-4.88
-69.52%
Diluted Earnings per share
2.14
7.02
-4.88
-69.52%
Operating Profit Margin (Excl OI)
27.32%
46.58%
0.00
-19.26%
Gross Profit Margin
33.21%
45.88%
0.00
-12.67%
PAT Margin
21.75%
34.40%
0.00
-12.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,406.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.01% vs 2.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.93% vs 2.39% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 523.50 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 2.33% vs -0.70% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -52.40% vs 237.91% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 857.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 16.09% vs -16.86% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 6.32% vs 4.55% in Mar 2025

Quarterly - Interest
Interest 41.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -14.69% vs 29.97% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 45.64% vs 20.59% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.32%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025